Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03277924
Title Trial of Sunitinib Plus Nivolumab After Standard Treatment in Advanced Soft Tissue and Bone Sarcomas (ImmunoSarc)
Acronym ImmunoSarc
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Grupo Espanol de Investigacion en Sarcomas
Age Groups: adult | child | senior
Covered Countries ITA | GBR | ESP

No variant requirements are available.